Talking Biotech with Dr. Kevin Folta Identifying Rare Compounds with A.I.
While genomics approaches have opened a universe of new compounds in plants, the vast majority remain uncharacterized. Brightseed has employed an artificial intelligence platform to scan for novel compounds, with a goal to identify new chemicals that may play a role in human health. Today’s podcast features Dr. Jim Flatt, CEO and Co-Founder of Brightseed. He discusses the company’s pilot products and the pipeline of compounds that may enhance human health.
www.brightseedbio.com
# COLABRA
Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/
# TALKING BIOTECH
Twitter: https://twitter.com/talkingbiotech
Website: https://www.colabra.app/podcasts/talking-biotech/
Instagram: https://www.instagram.com/colabrahq
The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.